SLIDE 6 4/16/2016 6
30 Day Outcomes Overall (N=168) Stage 1 (N=21, 13%) Stage 2 (N=48, 29%) Stage 3 (N=42, 25%) Stage 4 (N=49, 29%) P- Value Mortality 3% 0% 4% 7% 0% 0.27 MACE 8% 0% 13% 10% 4% 0.33 MALE 4% 0% 0% 5% 6% 0.24 Readmission 21% 14% 21% 17% 29% 0.54 Hospital Length of Stay (days) 12 8 11 8 18 0.02 Midterm Outcomes Survival 85% 100% 80% 83% 88% 0.10 Major Amputation 10% 0% 8% 5% 20% 0.037 MALE 19% 0% 19% 14% 31% 0.018 Amputation Free Survival 77% 100% 75% 79% 69% 0.048 MALE Free Survival 70% 100% 67% 71% 59% 0.022
30- Day and midterm outcomes stratified by SVS Threatened Limb Classification System (WIfI)
Causey MW et al J Vasc Surg (in press)
Overall (N=168) Stage 1 (N=21, 13%) Stage 2 (N=48, 29%) Stage 3 (N=42, 25%) Stage 4 (N=49, 29%) P- Value Revascularization (Any) 71% 29% 75% 64% 90% 0.001 Infrainguinal Revasc. 64% 14% 60% 62% 90% 0.001 Endovascular 50 (46%) 1(33%) 8(28%) 13(50%) 25(57%) 0.17 Surgical 58(54%) 2(67%) 21(72%) 13(50%) 19(43%) 0.17 Podiatric Procedures
1.4 1.5 0.7 1.2 2.3 0.001 Minor Amputation 71(42%) 8(38%) 6(13%) 20(48%) 34(69%) 0.001 Digital 52(31%) 8(38%) 4(8%) 16(38%) 21(43%) 0.003 Transmetatarsal 33(20%) 1(5%) 2(4%) 6(14%) 22(45%) 0.001 Hindfoot procedure 8(5%) 0(0%) 0(0%) 0(0%) 8(16%) 0.001
Summary of Procedures
Causey MW et al J Vasc Surg (in press)
All Rutherford 5!!
Magnitude of perfusion increase and durability required may vary for different settings of “CLI” The modern definition of “Critical” limb ischemia is called into question
Speaker Name
Summary of Current Classifications
Classification Rest Pain Ulcer Gangrene Ischemia Infection Rutherford √ √ √ √ Fontaine √ √ √ √ PEDIS √ √ √ UT √ √ √ Wagner √ √ SAD system √ √ Saint Elian √ √ √ IDSA √ SVS √ √ √ √ √